IRF2BP2 and acute lymphoblastic leukemia: In this study, we identified an SE region with high frequency of occurrence in samples from 7 pediatric T‐ALL patients and 6 T‐ALL cell lines, and this SE can activate interferon regulatory factor 2 binding protein 2 (IRF2BP2).